340Banter Podcast

Understanding Recent Changes to the BPHC Site Visit Protocol

How often do HRSA Operational Site Visits (OSVs) occur, and what exactly are reviewers looking for during these important compliance assessments?
In this episode of 340Banter, Chelsea Violette and Logan Yoho discuss recent updates to HRSA's Operational Site Visit (OSV) Protocol and how the changes help clarify expectations for health centers navigating compliance requirements.
A key focus of the conversation is the Sliding Fee Discount Program (SFDP), an area that has historically created confusion during site visits. Chelsea and Logan break down the latest protocol updates, explain what has changed, and discuss how health centers can better prepare for OSV reviews by understanding HRSA's current expectations.
Whether you're a CEO, COO, compliance officer, operations leader, or health center administrator, this episode provides practical insights to help your organization stay informed and prepared for HRSA oversight activities.
Let’s connect:https://www.fqhc340b.com/info@fqhc340b.com(760) 780-7469

Making Sense of Non-Standardized Financial Reporting in the 340B Program

What do all those 340B financial reports actually mean, and how can organizations make sense of them when every vendor seems to report data differently?
In this episode of 340Banter, Chelsea Violette and Logan Yoho sit down with Michael Gonzalez, Founder of FQHC 340B Compliance, to unpack one of the biggest operational challenges facing 340B Programs today: navigating non-standardized financial reporting across TPAs, pharmacy platforms, and vendor systems.
From confusing terminology and inconsistent report formats to understanding what metrics truly matter, this conversation explores how covered entities can better track the financial performance and overall health of their 340B Program. Michael shares practical strategies for improving visibility into savings, identifying reporting gaps, monitoring trends over time, and creating a more proactive approach to financial oversight and compliance.
Whether you're a 340B coordinator, CFO, pharmacy leader, or compliance professional, this episode delivers valuable insight into how organizations can strengthen financial monitoring, ask better questions of their vendors, and maintain a clearer pulse on the sustainability and performance of their 340B operations.
Let’s connect: https://www.fqhc340b.com/ | info@fqhc340b.com

Episode 29: Understanding Annual Single Audits in the 340B Program with Michael Gonzalez

What exactly is an Annual Single Audit, and why does it matter for organizations participating in the 340B Drug Pricing Program? In this episode of 340Banter, Chelsea Violette and Logan Yoho sit down with Michael Gonzalez, Founder of FQHC 340B Compliance, to break down the essentials of the Single Audit process and its critical connection to pharmacy operations within 340B Programs.
Whether you're a compliance officer, healthcare administrator, or pharmacy leader, this episode delivers practical insights into how federal audit requirements impact covered entities, funding accountability, and 340B Program integrity. Learn how Single Audits evaluate financial controls, ensure compliance with federal regulations, and influence pharmacy partnerships and contract pharmacy oversight.

From Pharmacist to Community Health Center CEO

Donavan received his Bachelor’s degree in pharmacy from the University of Utah College of Pharmacy in 1995. His past work experience includes being a retail pharmacist at Albertsons, a Director of Pharmacy at Gunnison Valley Hospital, and a Director of Pharmacy at Central Valley Medical Center. While at Gunnison Valley Hospital, he sat on the Pharmacy and Therapeutics committee and was an active member of the Gunnison Valley Hospice program. In addition, Donavan was an adjunct faculty member at the Snow College Richfield Allied Health department for 6 years, where he developed and taught the pharmacy technician program. In 2005, he started his current position as the Director of Pharmacy at the Wayne Community Health Center in Bicknell, Utah. In 2007, Donavan received the Stephen D. Ratcliff award from the Association of Utah Community Health Centers in recognition of his efforts as a positive visionary leader. From spring 2012 to 2014, Donavan served 2 years as a 340B Peer-to-Peer Mentor with the American Pharmacists Association Federal Contracts and Grants. During this time, he received the Peer All-Star Award and Peer Spirit Award. Donavan sits on the Apexus 340B Prime Vendor Program Advisory Council for Federally Qualified Health Centers. As a Director of Pharmacy, Donavan has helped spearhead the chronic pain management program at Wayne Community Health Center. This program received recognition in 2010 from the Sevier Valley Substance Abuse Coalition for its outstanding efforts in the fight against prescription drug abuse. He sits on the P&T committee and is an active member of the clinical multidisciplinary team and the Emergency room team. During his employment with Wayne Community Health Center, he has helped implement and manage the acute coronary treatment program, including the usage of thrombolytics in a rural clinic 60 miles away from the nearest hospital and 160 miles from the nearest acute cardiac center. In 2018 and 2019, Donavan and Zackery Taylor, PharmD. Wayne Community Health Center became the first open-door telepharmacy-retail pharmacy for a remote dispensing site located in Green River, Utah.

On the Frontlines of MFP: Challenges, Decisions, and What Comes Next

On this episode of 340Banter, Donovan Smith, CEO of Wayne Community Health Centers, details the real-world impact of the IRA’s Maximum Fair Price (MFP) implementation. He explains how claims are being misattributed to 340B, the challenges of a dual inventory model in a remote pharmacy, the financial strain from denied rebates and low dispensing fees, and the risks to patient access. Donovan also discusses advocacy efforts and potential fixes to make the process fairer for small, rural safety-net providers.

Resetting Your Mindset & Learning Habits

In this episode, we explore a powerful and timely topic: How to reteach yourself how to learn. Whether you’re returning to school, starting a new career, rebuilding confidence, or simply feeling stuck, learning as an adult can feel very different than it did before. The good news? Learning is a skill, and it can be rebuilt. This conversation dives into the mindset shifts, habits, and strategies that help you become a better learner again, especially in a world full of distractions, burnout, and information overload. If you’ve ever thought, “I don’t know how to learn anymore,” this episode is for you. 👉 Subscribe for more conversations on personal growth, mindset, productivity, and lifelong learning.

MFP Drugs Update: The First Drugs Selected for Maximum Fair Price

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho take a closer look at MFP Drugs, the first prescription medications selected for Maximum Fair Price (MFP) under Medicare’s new drug pricing authority.With Medicare now negotiating prices for some of the most widely used and expensive drugs in the U.S., the spotlight is on how these MFP drug selections will affect patients, manufacturers, providers, and the broader healthcare marketplace.Chelsea and Logan break down what it means to be an “MFP drug,” how the negotiation process works, and what stakeholders should be watching as implementation continues.If you work in healthcare policy, pharmacy, drug pricing, Medicare, or 340B compliance, this is a must-listen conversation on one of the biggest shifts in pharmaceutical reimbursement in decades.👉 Subscribe for more weekly discussions on 340B, Medicare reform, drug pricing policy, and healthcare legislation.

Maximum Fair Price: The Reality So Far

In this episode of the 340Banter Podcast, co-hosts Chelsea Violette and Logan Yoho break down the latest on Maximum Fair Price (MFP) under the Inflation Reduction Act and ask the big question: How’s it going so far?As Medicare drug price negotiations move from policy theory to real-world implementation, stakeholders across the healthcare system are feeling the impact. Chelsea and Logan unpack what MFP means for drug manufacturers, hospitals, providers, patients, and the 340B program, and explore early reactions, operational challenges, and what comes next.Whether you work in health policy, pharmaceutical pricing, hospital administration, or government affairs, this episode delivers a clear, insightful update on one of the most significant drug pricing reforms in decades.Stay informed on the policies shaping the future of healthcare.👉 Subscribe to the 340Banter Podcast for weekly insights on 340B, drug pricing reform, healthcare legislation, and pharmaceutical policy.

Optimizing Clinical Pharmacy Services Under 340B: Strategies & Best Practices

Running a clinical pharmacy under 340B isn’t just about discounts; it’s about delivering high-quality care and maximizing the program's value. Jamie Kim shares strategies for using 340B savings to expand clinical pharmacy services, improve patient access, and enhance outcomes while remaining compliant. This episode is especially helpful for administrators and pharmacy directors looking to get the most out of 340B.

Health Center UDS Reporting: Including Pharmacy & 340B in Your Metrics

Accurate UDS reporting is crucial for health centers, but many overlook the role of pharmacy operations and 340B activity in this process. Matthew Krah walks listeners through key considerations for integrating pharmacy and 340B data into Uniform Data System (UDS) reporting. Learn how to ensure your 340B-related prescriptions and savings are properly documented, and avoid common reporting mistakes.